Evidence map›Paper›PMID 37104728›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer.

Celine M Vachon, Christopher G Scott, Aaron D Norman, Sadia A Khanani, Matthew R Jensen, Carrie B Hruska, Kathleen R Brandt, Stacey J Winham, Karla Kerlikowske

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Response to Omoleye, Esserman, Olufunmilayo.Journal of the National Cancer Institute · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Celine M VachonDivision of Epidemiology, Department Quantitative Sciences, Mayo Clinic, Rochester, MN.ORCID 0000-0002-1962-9322
Christopher G ScottDivision of Clinical Trials and Biostatistics, Department Quantitative Sciences, Mayo Clinic, Rochester, MN.ORCID 0000-0003-1340-0647
Aaron D NormanDivision of Epidemiology, Department Quantitative Sciences, Mayo Clinic, Rochester, MN.ORCID 0000-0002-4208-2708
Sadia A KhananiDivision of Breast Imaging, Department of Radiology, Mayo Clinic, Rochester, MN.
Matthew R JensenDivision of Clinical Trials and Biostatistics, Department Quantitative Sciences, Mayo Clinic, Rochester, MN.
Carrie B HruskaDivision of Breast Imaging, Department of Radiology, Mayo Clinic, Rochester, MN.ORCID 0000-0002-6195-5201
Kathleen R BrandtDivision of Breast Imaging, Department of Radiology, Mayo Clinic, Rochester, MN.
Stacey J WinhamDivision of Computational Biology, Department Quantitative Sciences, Mayo Clinic, Rochester, MN.ORCID 0000-0002-8492-9102
Karla KerlikowskeUniversity of California, San Francisco, CA.ORCID 0000-0001-8793-8779
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of California, San Francisco · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
Radiomic phenotypes of breast parenchyma and association with breast cancer risk and detectionR01CA207084 · NCI · MAYO CLINIC ROCHESTER · PI KERLIKOWSKE, KARLA M, KONTOS, DESPINA · 2017 to 2021
$3.2M
Automated Density Measures for Estimating Breast Cancer Risk and Therapy ResponseR01CA177150 · NCI · MAYO CLINIC ROCHESTER · PI KERLIKOWSKE, KARLA M, VACHON, CELINE M · 2013 to 2017
$3.0M
Evaluation of novel tomosynthesis density measures in breast cancer risk predictionR01CA275074 · NCI · MAYO CLINIC ROCHESTER · PI KARLA M KERLIKOWSKE, Despina Kontos · 2023 to 2026
$2.7M
NCI NIH HHS P01 CA154292NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA177150NCI NIH HHS R01 CA207084NCI NIH HHS R01 CA275074
6 · The paper itself

Abstract

purposeArtificial intelligence (AI) algorithms improve breast cancer detection on mammography, but their contribution to long-term risk prediction for advanced and interval cancers is unknown.

methodsWe identified 2,412 women with invasive breast cancer and 4,995 controls matched on age, race, and date of mammogram, from two US mammography cohorts, who had two-dimensional full-field digital mammograms performed 2-5.5 years before cancer diagnosis. We assessed Breast Imaging Reporting and Data System density, an AI malignancy score (1-10), and volumetric density measures. We used conditional logistic regression to estimate odds ratios (ORs), 95% CIs, adjusted for age and BMI, and C-statistics (AUC) to describe the association of AI score with invasive cancer and its contribution to models with breast density measures. Likelihood ratio tests (LRTs) and bootstrapping methods were used to compare model performance.

resultsOn mammograms between 2-5.5 years prior to cancer, a one unit increase in AI score was associated with 20% greater odds of invasive breast cancer (OR, 1.20; 95% CI, 1.17 to 1.22; AUC, 0.63; 95% CI, 0.62 to 0.64) and was similarly predictive of interval (OR, 1.20; 95% CI, 1.13 to 1.27; AUC, 0.63) and advanced cancers (OR, 1.23; 95% CI, 1.16 to 1.31; AUC, 0.64) and in dense (OR, 1.18; 95% CI, 1.15 to 1.22; AUC, 0.66) breasts. AI score improved prediction of all cancer types in models with density measures (

conclusionAI imaging algorithms coupled with breast density independently contribute to long-term risk prediction of invasive breast cancers, in particular, advanced cancer.

Indexed as

Breast NeoplasmsArtificial IntelligenceBreastBreast DensityEarly Detection of CancerFemaleHumansMammographyRetrospective Studies

Identifiers

PMID37104728
PMCPMC10256336
OpenAlexW4367173234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.